Prime Medicine, Inc.
PRME
$3.27
-$0.03-0.91%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.33% | -9.00% | 3.69% | 4.95% | -13.39% |
| Total Depreciation and Amortization | 9.18% | 9.26% | 20.73% | 21.20% | 29.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.48% | -27.10% | 63.74% | -32.80% | 31.18% |
| Change in Net Operating Assets | 67.33% | -97.63% | -96.43% | 111.54% | 74.58% |
| Cash from Operations | 12.58% | -329.34% | -35.22% | 8.97% | 27.84% |
| Capital Expenditure | 91.16% | 83.81% | 80.66% | 17.35% | -4.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 196.22% | -42.81% | -277.99% | -50.63% | -30.58% |
| Cash from Investing | 190.89% | -41.29% | -282.99% | -59.81% | -28.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 56,100.00% | 260.28% | 462.86% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -75.81% |
| Cash from Financing | -93.45% | 56,100.00% | 275.85% | 462.86% | -96.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.19% | -112.97% | -72.05% | 0.31% | -272.28% |